We investigated differences in L-type Ca 2ϩ current (ICa) between infant (INF, 1-12 mo old), young adult (YAD, 14-18 yr old), and older adult (AD) myocytes from biopsies of right atrial appendages. Basal ICa was smaller in INF myocytes (1.2 Ϯ 0.1 pA/pF, n ϭ 29, 6 Ϯ 1 mo old, 11 patients) than in YAD (2.5 Ϯ 0.2 pA/pF, n ϭ 20, 16 Ϯ 1 yr old, 5 patients) or AD (2.6 Ϯ 0.3 pA/pF, n ϭ 19, 66 Ϯ 3 yr old, 9 patients) myocytes (P Ͻ 0.05). Maximal ICa produced by isoproterenol (Iso) was similar in INF, YAD, and AD cells: 8.4 Ϯ 1.1, 9.6 Ϯ 1.0, and 9.2 Ϯ 1.3 pA/pF, respectively. Efficacy (E max) was larger in INF (607 Ϯ 50%) than for YAD (371 Ϯ 29%) or AD (455 Ϯ 12%) myocytes. Potency (EC 50) was 8-to 10-fold higher in AD (0.82 Ϯ 0.09 nM) or YAD (0.41 Ϯ 0.14 nM) than in INF (7.6 Ϯ 3.5 nM) myocytes. Protein levels were similar for Gi␣2 but much greater for Gi␣3 in INF than in AD or YAD atrial tissue. When Gi␣3 activity was inhibited by inclusion of a Gi␣3 COOH-terminal decapeptide in the pipette, basal ICa and the response to 10 nM Iso were increased in INF, but not in YAD, cells. We propose that basal ICa and the response to low-dose ␤-adrenergic stimulation are inhibited in INF (but not YAD or AD) cells as a result of constitutive inhibitory effects of Gi␣3.
L-TYPE CALCIUM CURRENT (I Ca ) is a major determinant of the early plateau phase of the action potential and is the trigger (combined with Ca 2ϩ release from the sarcoplasmic reticulum) for contraction in heart cells. The enhancement of I Ca in cardiac cells by ␤-adrenergic agonists is a mechanism for regulating heart rate and contractility by sympathetic nerve stimulation. During fetal and postnatal cardiac development, various changes occur in the cardiac contractile apparatus, sarcoplasmic reticulum, metabolic sensitivity, and hormonal regulation. However, little is known about the developmental changes in regulation of ionic currents and Ca 2ϩ handling. The regulation of I Ca is a complex interaction among many factors, including the voltage and time dependence of Ca 2ϩ channels, intracellular release of Ca 2ϩ , circulating catecholamines, Ca 2ϩ channel density, and effects of many pharmacological agents, as well as interactions between adenylyl cyclase, cyclic nucleotides, and G proteins. The basal levels of I Ca , as well as the amplitude and time course of various K ϩ currents, in human infant atrial cells may be different from those in human adult atrial cells, and these differences may be important in the in vivo electrical and mechanical properties of the atrium. Differences in the waveform of the action potentials lead to differences in the refractory period and, thus, may be important in the genesis and maintenance of atrial arrhythmias.
Various animal studies on developmental changes in regulation of I Ca were primarily focused on ventricular cells. We previously demonstrated (13, 19) lower I Ca density (pA/pF) and less sensitivity to stimulation by isoproterenol (Iso) in newborn than in adult rabbit ventricular cells. We further showed (11) a tonic inhibition by inhibitory G proteins in newborn cells, which could account for their lower basal I Ca amplitude and decreased potency for Iso stimulation. In other species, e.g., rat (7), newborn cells have been shown to have higher I Ca than adult cells. In a previous study on I Ca amplitude in human infant vs. adult atrial cells (21) , no differences were found. In this study, the amplitude of I Ca in infant hearts (1-12 mo old) was 1.0-1.2 pA/pF, while that in adult (47-79 yr old) atrial cells was somewhat larger (1.5-1.8 pA/pF) but not significantly different.
Measurements of I Ca from isolated adult human atrial cells at room temperature have been reported with a variety of "basal" I Ca amplitudes: from 1.2 Ϯ 0.1 to 12 Ϯ 4 pA/pF (5, 10, 16, 17, 20, 21, 24, 26) . Similarly, the maximum effect of Iso to stimulate I Ca in adult human atrial cells has also been reported with considerable variability: from 150 to 853% (5, 16, 20, 24) . In the present study, we have isolated human atrial cells from older adult, young adult, and infant patients to determine whether the basal I Ca and the sensitivity to Iso in infant cells is less than that in adult cells and, if so, whether these changes occur early or late in life.
MATERIALS AND METHODS

Patients.
Biopsies from the right atrial appendage were obtained at the time of initiation of cardiopulmonary bypass from older adult (AD, 51-79 yr old, n ϭ 11), young adult (YAD, 14-18 yr old, n ϭ 6), and infant (INF, 3-10 mo old, n ϭ 19) patients. The percentages of the patients that were female were 45% of AD, 17% of YAD, and 42% of INF. All the patients were in normal sinus rhythm at the time of surgery, with no documented history of previous atrial fibrillation or atrial dilation. The characteristics of AD, YAD, and INF patients are given in Table 1 , as well as whether the biopsy was used to study I Ca and/or for Western blot analysis. The study protocols for using adult and infant atrial biopsies were approved by the Emory University Human Investigation Committee and by Children's Healthcare of Atlanta.
Preparation of isolated cells. As in our previous work (29) , atrial tissue obtained at the time of surgery was placed in oxygenated Ca 2ϩ -free Krebs-Ringer (KR) solution and transported to the laboratory within 5 min after excision and cut into small chunks. Tissue chunks were stirred in oxygenated Ca 2ϩ -free KR solution at 34-36°C, and the solution was changed three times. After 15 min, the solution was replaced with Ca 2ϩ -free KR solution ϩ collagenase (1 mg/ml, type I; Sigma), protease (0.4 mg/ml, type XXIV; Sigma), and BSA (1 mg/ml) for 40 min. Tissue was transferred to Ca 2ϩ -free KR solution ϩ collagenase (1 mg/ml, type I; Sigma). Tissue chunks were triturated, and the supernatant was tested every 15 min under the microscope until cells started to appear. Cells were then separated by centrifugation and resuspended in storage solution containing 10 mg/ml BSA and kept in a refrigerator until they were used.
Recording whole cell I Ca. The cells were placed in a chamber that was continuously perfused with normal test solution at room temperature, as in our previous work with rabbit ventricular cells (19) . Whole cell voltage-clamp experiments were performed with pipette resistances of 1.0-2.0 M⍀ with compensation for capacitance and series resistance but without leak correction. The cell was depolarized every 10 s from a holding potential (V h) of Ϫ45 mV to a test potential of ϩ10 mV for 360 ms. In each age group, we also performed experiments using a V h of Ϫ80 mV with a prepulse of 200 ms to Ϫ45 mV to inhibit Na ϩ current and found nearly identical values of ICa without and with Iso compared with using a Vh of Ϫ45 mV. The potential of the pipette was set to zero within the bath solution, and no compensation was made for differences in tip potential during exposure to the cytoplasmic solution. We express all the current data as current density (pA/pF) by normalizing the current for each cell to its capacitance. Cells that showed rundown were excluded from analysis. Modifications to these solutions are described below for specific protocols. The "EC" peptide as used previously by Aridor et al. (3) and in our previous study (11) to inhibit G i␣3 is a synthetic decapeptide corresponding to the COOH terminus of Gi␣3 and was produced in the Emory University Microchemistry Facility.
Determination of G protein levels by Western blotting. We analyzed amounts of G i␣2 or Gi␣3 in total homogenates from INF, YAD, and AD atrial biopsies as we previously described (13, 18) . We used polyclonal antibodies for G i␣2 (Santa Cruz Biotechnology) at 1:500 dilution and for Gi␣3 (Calbiochem) at 1:1,000 dilution. For detection of bands, we used an enhanced chemiluminescence detection kit (ECL plus, Amersham) with Lumigen PS-3 substrate. To compare relative amounts of specific proteins in multiple lanes, we analyzed immunostained bands with a two-dimensional gel imaging system and LabWorks image acquisition and analysis software (UVP, Upland, CA) with data presented as arbitrary optical density units.
Statistics. Values are means Ϯ SE. Comparison of measured parameters was done using ANOVA. Student-Newman-Keuls post hoc test was used to compare variations between groups. P Ͻ 0.05 was defined as significant. Figure 1A shows data from an INF (9 mo old) atrial cell [capacitance (C m ) ϭ 27 pF] with a control I Ca density of 1.5 pA/pF, which increased to 8.3 pA/pF with 100 nM Iso. Figure 1B shows data from a YAD (19-yrold) atrial cell (C m ϭ 67 pF) with a control I Ca of 2.4 pA/pF, which increased to 9.9 pA/pF with 100 nM Iso. Figure 1C shows data from an AD (75-yr-old) atrial cell (C m ϭ 51 pF) with a control I Ca of 2.3 pA/pF, which increased to 10.5 pA/pF with 100 nM Iso. The voltage step is to ϩ10 mV from a V h of Ϫ45 mV.
RESULTS
Basal and
Because we recorded I Ca from all the cells as a voltage step to ϩ10 mV, we needed to show that this voltage step was appropriate for determining the maximum I Ca in control solution and in Iso. Figure 2A shows current-voltage relations for I Ca recorded from some of the INF, YAD, and AD cells in control solution and in 100 nM Iso produced by a sequence of voltage steps (each from V h ϭ Ϫ45 mV) to ϩ40 mV, with the peak I Ca plotted against the test potential. In control solution, the maximum current was obtained at ϩ10 or ϩ15 mV in each age group; in the Iso solution the curves shift leftward, as expected, and the peak occurred at ϩ5 or ϩ10 mV. We used a test potential of ϩ10 mV for the measurements of peak I Ca density reported below.
To determine whether there are developmental changes in the basal I Ca and in the response of I Ca to Iso, we recorded I Ca from a total of 29 INF (from 11 INF patients), 19 AD (from 9 AD patients), and 20 YAD (from 5 YAD patients) human atrial cells. For all these cells, we also recorded I Ca after exposure to one or more concentrations of Iso and compared the data among the three age groups. Figure 2B The concentration-dependent effect of Iso on I Ca for INF, YAD, and AD human atrial cells is summarized in Fig. 3 , plotted as the percent increase in I Ca as a function of Iso concentration. The data were fit using the logistic equation to determine E max and EC 50 for the different age groups. For INF atrial cells (Fig. 3A) , the calculated E max was 607 Ϯ 50%, while EC 50 was 7.6 Ϯ 3.5 nM. For YAD cells (Fig. 3B) , EC 50 was 0.41 Ϯ 0.05 nM, with E max of 371 Ϯ 29%. For AD atrial cells (Fig. 3C) , EC 50 was 0.82 Ϯ 0.09 nM, with E max of 455 Ϯ 12. The AD and YAD cells are similar, in that they have a high potency for Iso (EC 50 Ͻ 1 nM), with E max of ϳ400%. INF cells are distinctly different from AD and YAD cells, in that they have a lower potency (higher EC 50 by a factor of ϳ10), a broader dose-response curve, and a higher E max in terms of percent change by Iso (although not a higher level of I Ca produced by Iso; Fig. 2) .
Comparison between effects of Iso and cAMP in AD and INF human atrial cells. It is not always the case that Iso can maximize I Ca in cardiac cells. To examine the maximal stimulation of I Ca by activation of the PKA pathway, we applied 100 M cAMP by intracellular dialysis to AD and INF human atrial cells. We previously showed that intracellular application of 100 M cAMP increased I Ca maximally in adult rabbit atrial cells (28) as well as in newborn and adult rabbit ventricular cells (19) but that the maximum effects of Iso were significantly less than those of intracellularly applied cAMP in newborn rabbit ventricular cells. For the human AD atrial cells, there was no significant difference between maximal I Ca densities obtained with externally applied Iso (9.2Ϯ1.3 pA/pF, n ϭ 6) and internally applied 100 M cAMP (11.5 Ϯ 1.8 pA/pF, n ϭ 3). For INF human atrial cells, the maximal value of I Ca achieved with intracellular application of cAMP was 9.4 Ϯ 0.7 pA/pF (n ϭ 8), which was not significantly different from the maximal I Ca obtained with Iso (8.4 Ϯ 1.1 pA/pF, n ϭ 5). Thus it appears that Iso can maximize I Ca in AD and INF human atrial cells, although with a higher EC 50 for INF cells, which is distinctively different from the results we obtained with the newborn and adult rabbit ventricular cells (19) .
Levels of G i protein isoforms in AD, YAD, and INF atrial tissue. The data reported above showing decreased basal I Ca and a decreased potency for Iso stimulation for INF cells vs. YAD or AD cells represent developmental differences similar to those we showed previously for newborn vs. adult rabbit ventricular cells. In the rabbit cells, we also showed that levels of G i proteins were significantly greater in newborn than in adult ventricular cells and that a tonic inhibitory effect from these G proteins was part of the mechanism for the developmental differences in I Ca amplitude and Iso sensitivity. To determine whether there are developmental differences in G i proteins in human atrial cells, we obtained proteins from three AD, three YAD, and four INF atrial biopsies for comparisons by Western blotting. Figure 4 shows Western blots of total homogenate protein prepared from atrial biopsies obtained from INF and AD patients. Protein levels for G i ␣ 2 (Fig. 4, top) are similar for the two age groups, whereas protein levels for G i ␣ 3 (Fig. 4 , bottom) are clearly higher for the INF patients than for the AD patients. Densitometric analysis of INF and AD bands (optical density in arbitrary units) showed that G i ␣ 2 in INF patients (252 Ϯ 17, n ϭ 3) was not significantly different from that in AD patients (211 Ϯ 64, n ϭ 3). However, G i ␣ 3 in INF tissue (298 Ϯ 37, n ϭ 3) was 13 times greater (P Ͻ 0.05) than the mean level of G i ␣ 3 in AD tissue (22 Ϯ 10, n ϭ 3). The Western blots in Fig. 5 show relative amounts of G i ␣ 2 and G i ␣ 3 in INF vs. YAD tissue. Densitometric analysis of INF and YAD bands (optical density in arbitrary units) showed that G i ␣ 2 in INF patients was not significantly different from that in YAD patients: 104 Ϯ 6 vs. 85 Ϯ 5 (n ϭ 3). However, G i ␣ 3 was six times greater in INF tissue than in YAD tissue: 61 Ϯ 16 vs. 11 Ϯ 6 (n ϭ 3, P Ͻ 0.05). These results show similar levels of G i ␣ 2 in INF and YAD atrial tissue but much lower levels of G i ␣ 3 in YAD than in INF tissue, the same relation we showed for AD tissue. In our previous work with rabbit ventricular cells, G i ␣ 2 and G i ␣ 3 were significantly greater in newborn than in adult cells (13) ; this finding differs from the results obtained in the present study for human atrial cells. Table 1 ) and 3 AD (patients 4, 7, and 11 in Table  1 ) patients, respectively. Table 1 ) and 3 YAD (patients 1, 3, and 4 in Table  1 ) patients, respectively.
Effects of a decapeptide corresponding to the COOH terminus of G i ␣ 3 .
To determine whether G i proteins, specifically G i ␣ 3 , are playing a tonic inhibitory role in basal I Ca levels in INF, but not in YAD, atrial cells, we carried out experiments to determine whether the addition of a decapeptide corresponding to the COOH terminus of G i ␣ 3 (EC peptide) to the pipette solution would increase basal I Ca in INF, but not in YAD, atrial cells. Additionally, we determined whether EC peptide increased the sensitivity of the response of INF atrial cells to Iso. In these experiments, we included EC peptide in the pipette solution; thus we cannot record a stable basal I Ca without the effect, if any, of EC peptide. Thus we compared cells for which EC peptide was in the pipette solution with other cells (from the same age group) for which EC peptide was not in the pipette. Figure 6 , left, shows current traces from an INF atrial cell with 500 g/ml EC peptide in the pipette. For nine INF cells, we recorded basal I Ca with the EC peptide in the peptide and also applied one or more concentrations of Iso. The basal I Ca with EC peptide in the pipette (2.2 Ϯ 0.3 pA/pF, n ϭ 9) was significantly greater than the basal I Ca without EC peptide in the pipette (1.2 Ϯ 0.1 pA/pF, n ϭ 29). In addition, the I Ca for 10 nM Iso with EC peptide in the pipette (8.1 Ϯ 1.0 pA/pF, n ϭ 5) was significantly greater than the I Ca for 10 nM Iso without EC peptide in the pipette (4.7 Ϯ 0.4 pA/pF, n ϭ 14). However, the current with 100 nM Iso (with EC peptide) was 7.5 Ϯ 0.1 pA/pF, which was not significantly different from the current for INF atrial cells with 100 nM Iso (without EC peptide): 8.4 Ϯ 1.0 pA/pF. Thus the presence of EC peptide increased the basal I Ca and the I Ca at intermediate levels of Iso but not the maximum obtainable I Ca for these INF cells.
The Iso dose response for INF atrial cells with EC peptide in the pipette is shown in Fig. 6 , right. For INF cells, the E max for Iso with EC peptide in the pipette was considerably reduced compared with the E max for Iso without EC peptide in the pipette. Similarly, the EC 50 for Iso with EC peptide in the pipette was also considerably reduced compared with the EC 50 for Iso without EC peptide in the pipette. For INF cells, the presence of EC peptide in the pipette made the values of EC 50 and E max close to those obtained for YAD or AD cells without EC peptide in the pipette.
To determine whether the effects of EC peptide on basal I Ca were present exclusively for INF cells, we also recorded from six cells from YAD patients with the same EC peptide in the pipette and obtained values of basal I Ca (2.7 Ϯ 0.6 pA/pF) and I Ca with 10 nM Iso (9.0 Ϯ 1.0 pA/pF, n ϭ 4) that were not significantly different from the values for YAD atrial cells without EC peptide in the pipette (2.5 Ϯ 0.2 and 10.0 Ϯ 1.4 pA/pF for basal I Ca and I Ca with 10 nM Iso, respectively); these data show that EC peptide did not affect the basal I Ca or the maximum Iso effect on I Ca for YAD cells.
DISCUSSION
Our data indicate significant differences in the amplitude and regulation of I Ca of infant vs. young or older adult human atrial cells as determined by square-wave voltage-clamp waveforms at room temperature. Specifically, the basal I Ca and the potency for Iso stimulation are lower for infant than for young and older adult cells. However, the magnitude of the maximal I Ca obtained with direct dialysis of cAMP into the cells or with maximal levels of Iso was not different for infant vs. adult cells.
Our studies on amplitude and regulation of I Ca were done at room temperature to maximize the stability of the preparations. (9) for I Ca from infants from 3 days to 4 yr of age. In the study by Roca et al. (21) , the amplitude of I Ca from infant atrial cells (1-12 mo old) was 1.0-1.2 pA/pF, which is not largely different from our results for infants of the same age range (1.2 Ϯ 0.1 pA/pF), whereas their amplitude for adult human atrial cells (47-79 yr old, 1.5-1.8 pA/pF) is less than the 2.6 Ϯ 0.3 pA/pF we obtained and may explain why we demonstrated a significant difference between infant and adult cells and they did not.
Prior studies on the amplitude of I Ca of adult human atrial cells at physiological temperature have shown, as expected, higher amplitudes of I Ca , with reported values of 6.76 Ϯ 1.14 pA/pF (30), 9.3 Ϯ 1.0 pA/pF (27), 10.4 pA/pF (1), and 10.8 Ϯ 1.1 pA/pF (14) . We recently reported (29) a value of 4.1 Ϯ 0.4 pA/pF for peak I Ca of infant human atrial cells at physiological temperature. These data suggest that the approximately twofold difference in basal current between infant and adult human atrial cells persists at physiological temperature, but compara- 34%) is considerably reduced compared with that for Iso without EC peptide in the pipette (607 Ϯ 50%, see Fig. 3 ). EC50 for Iso with EC peptide in the pipette (1.1 Ϯ 0.6 nM) is also considerably reduced compared with that for Iso without EC peptide in the pipette (7.6 Ϯ 3.5 nM, see Various biochemical studies have been done to compare atrial tissue from children and adults with regard to different components of the regulatory pathways for I Ca . Brodde et al. (6) analyzed specimens of right atrial appendage from children (3.7 Ϯ 1 yr old) vs. adults (37.9 Ϯ 2.3 yr old) vs. older adults (66.1 Ϯ 1.5 yr old). Neither the ␤-adrenoceptor number (fmol iodocyanopindolol/mg protein) nor the ␤ 1 -to-␤ 2 ratio were different among the three groups. However, adenylyl cyclase basal and stimulated activity (pmol cAMP⅐mg protein Ϫ1 ⅐ min Ϫ1 ) were higher in the children than in the adults or older adults. Although G s ␣ levels were not different for the three age groups, G i ␣ levels (with use of an antibody that detects G i ␣ 1 , G i ␣ 2 , and transducin) at 37 and 46 kDa were slightly higher in the older adults. However, specific comparisons of G i ␣ 1 , G i ␣ 2 , and G i ␣ 3 were not reported. We previously showed (13) developmental differences of rabbit ventricular cells primarily in G i ␣ 2 and G i ␣ 3 . These G i ␣ changes also led to a greater sensitivity to carbachol and adenosine for inhibiting I Ca , which had been enhanced by Iso in newborn compared with adult rabbit ventricular cells (13) . Suto et al. (25) showed a similar increased neonatal sensitivity to adenosine in inhibiting Isostimulated I Ca in rabbit atrial cells. The varying age ranges of the "children" groups of these biochemical studies make it difficult to extrapolate to our studies on infant (Ͻ1 yr old) vs. young or older adult atrial cells. Our Western blotting studies show that infant atrial tissue has similar levels of G i ␣ 2 but much greater levels of G i ␣ 3 than young or older adult human atrial tissue. These results suggest that one mechanism of lower basal I Ca and lower potency for Iso in infant cells than in adult cells may be constitutive activity of G i ␣ 3 , producing a tonic inhibition of adenylyl cyclase activity in the infant cells. Our results using EC peptide in the pipette solution for INF or YAD cells showed that inclusion of EC peptide in the pipette increased the basal I Ca and the 10 nM Iso-stimulated I Ca in the INF cells but not the 100 nM Iso-stimulated I Ca in the INF cells. However, EC peptide had no effect on the basal I Ca or the 10 nM Iso-stimulated I Ca in the YAD cells, which is consistent with our proposal of a tonic inhibition via G i ␣ 3 in INF, but not in YAD or AD, cells. EC peptide decreased E max and EC 50 of INF cells close to the levels of AD and YAD cells without EC peptide. Constitutive activity of a wide variety of G protein-coupled receptors is widely recognized (for review see Ref. 22 ) and has been shown specifically (23) for human adenosine A 1 receptors transfected into Chinese hamster ovary cells as a decreased GTP␥S binding in response to the application of inverse agonists. G protein ␣-subunits link to specific receptors by specific amino acid sequences at their COOH-terminal end. Freissmuth et al. (8) reported preferential coupling of G i ␣ 3 to adenosine A 1 receptors in a reconstituted system. They demonstrated that adenosine A 1 receptors had a 10-fold higher affinity for recombinant G i ␣ 3 synthesized in Escherichia coli (rG i ␣ 3 ) than for rG i ␣ 1 or rG i ␣ 2 and suggested that the specific coupling between adenosine A 1 receptors and G i ␣ 3 is likely to govern transmembrane signaling pathways in vivo. Aridor et al. (3) reported that the synthetic decapeptide (EC) that corresponds to the COOH-terminal end sequence of G i ␣ 3 specifically blocked the mastparan-and compound 48/80-induced histamine exocytosis from the mast cell. Aridor et al. (3) also showed that the inclusion of decapeptides corresponding to the COOH terminus of G i ␣ 1 or G i ␣ 2 had much smaller effects and that the inclusion of an irrelevant peptide of similar size had no effect. In our previous work on neonatal vs. adult rabbit ventricular cells (11), we showed that interruption of constitutive activity of G i ␣ 3 by the intracellular application of EC peptide increased basal I Ca , enhanced the Iso response, and blocked the inhibitory effects of adenosine for neonatal cells.
There are important differences between the results we demonstrated previously comparing newborn with adult rabbit ventricular cells (11-13, 15, 19) and the present work comparing infant with young or older adult human atrial cells. Newborn rabbit ventricular cells had decreased basal I Ca , increased EC 50 , and decreased E max for Iso stimulation compared with adult cells and also had higher levels of G i ␣ 2 and G i ␣ 3 than adult cells. Infant human cells have decreased basal I Ca and increased EC 50 for Iso stimulation but increased E max for Iso stimulation and increased levels of G i ␣ 3 , but not G i ␣ 2 , compared with young adult or older adult cells. In addition, for newborn, but not adult, rabbit ventricular cells, Iso was not able to increase I Ca to the maximum levels achieved with forskolin or intracellular cAMP. For human infant and adult atrial cells, the maximum current obtained with Iso was comparable to that obtained with intracellular cAMP, suggesting that the tonic inhibition of I Ca in infant human atrial cells was perhaps weaker than that observed in newborn rabbit cells, because it could be overcome by higher levels of Iso. This is consistent with our finding that the INF human atrial cells had higher levels of G i ␣ 3 , but not G i ␣ 2 , than YAD or AD atrial cells. There are other significant differences for newborn rabbit ventricular cells compared with adult rabbit ventricular cells that we have not evaluated for human atrial cells, including increased sensitivity to inhibitors of phosphatases or phosphodiesterases and increased inhibitory potency of adenosine and carbachol (2, 11, 15) .
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